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ABSTRACT
B. subtilis phage 029 has a terminal protein, p3, covalently
linked to the 5'ends of the DNA through a phosphodiester bond
between a serine residue and 5'-dAMP. This protein acts as a
primer in DNA replication by forming an initiation complex with
the 5'-terminal nucleotide dAMP.
The amino acid sequence of the terminal protein, deduced from
the nucleotide sequence of gene 3, showed the presence of 18 se-
rine residues in a total of 266 amino acids. In this paper we
have identified the serine involved in the linkage with the DNA
as the residue 232, located close to the C-terminus of the mole-
cule. This result was obtained by amino acid analysis of the pep-
tide that remains linked to the DNA after proteinase K digestion
of the terminal protein-029 DNA complex and automated Edman de-
gradation of the corresponding {125I}-labeled tryptic peptide.
Prediction of the secondary structure of the terminal protein
suggested that the serine residue involved in the linkage with
the DNA is placed in a 6-turn, probably located on the external
part of the molecule, as indicated by hydropathic values.
INTRODUCTION
B. subtilis phage 029 has a linear double-stranded DNA of
about 18,000 base pairs with a terminal protein covalently lin-
ked to the 5'ends through a phosphoester bond between the OH
group of a serine residue and 5'-dAMP, the terminal nucleotide
at both DNA ends (1). The terminal protein p3 has been characte-
rized as the product of gene 3 and plays a key role in the ini-
tiation of 029 replication that occurs at either DNA end by a
mechanism of protein priming (reviewed in 2). A newly synthesi-
zed molecule of the terminal protein is placed at either end of
the terminal protein-DNA complex, most probably by interaction
with the parental terminal protein and/or a specific sequence at
the ends of the DNA; in the presence of the viral DNA polymerase
an initiation complex p3-dAMP is formed, that provides the 3'-OH
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group needed for elongation. Adenovirus DNA also has a terminal
protein covalently linked by a phosphodiester bond between serine
and 5'-dCMP (3) and initiates replication by a similar protein
priming mechanism (reviewed in 4). Besides phage 029 and adenovi-
rus, a number of linear DNAs with terminal proteins have also
been found in quite unrelated organisms such as plasmid pSLA2
from Streptomyces (5), mitochondrial DNA Si and S2 from maize
(6), E. coli phage PRD1 (7) and phage Cp-1 (8) and related pha-
ges (9) from Streptococcus pneumoniae. The terminal protein-DNA
linkage, as determined in two cases, is a phosphodiester bond
between tyrosine and 5'-dGHP for PRD1 (10) and between threonine
and 5'-dAMP for Cp-1 (Garcia, P., Hermoso, J.M., Garcia, J.A.,
Garcia, E., L6pez, R. and Salas, M., submitted for publication).
The amino acid sequence of the terminal protein p3, deduced
from the nucleotide sequence of gene 3 (11), disclosed the exis-
tence of 18 serine residues in a total of 266 amino acids. To
better understand the protein priming mechanism we have determi-
ned the position in the terminal protein of the serine residue
that is linked to the DNA (linking site). In this paper we show
that the linking site is at position 232. The linking site has
been determined also in adenovirus (12). Secondary structure
predictiong in a region surrounding the linking sites in 029 and
adenovirus suggest that both serine residues lie in a s-turn
preceded by an a-helix. In addition, the hydropathic profiles of
those regions are similar and show that the linking sites of both
029 and adenovirus are probably placed at the external part of
the molecules.
iMATERIALS AND METHODS
Materials
Fungal proteinase K, chromatographically purified, pancrea-
tic carboxypeptidases A and B, piperidine and cellulose thin la-
yer chromatography plastic sheets were from Merck. Chloramine T,
trypsin, TPCK treated, from bovine pancreas, polybrene, 3-iodo-
tyrosine and the synthetic tetrapeptide pro-phe-gly-lys were fram
Sigma, sperm whale myoglobin from Beckman, guanidine hydrochlo-
ride from Schwarz/Mann and sodium iodine-{125I1, lOO mCi/ml
(3.76 Bq/ml) and {14C} methylated protein mixture of low molecu-
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lar weight markers from Amersham.
Purification and amino acid analysis of the proteinase K-resis-
tant peptide linked to 029-DNA
DNA from the phage $29 delayed lysis mutant susl4(1242) was
isolated by proteinase K digestion as described (13). The DNA
(50-70 mg) was diluted to a concentration of 1 mg/ml with a buf-
fer containing 0.5 M Tris-HCl, pH 8.0, 10 mM EDTA and 10 mM NaCl
and extracted three times with the same volume of phenol equili-
brated in this buffer. The DNA from the aqueous phases was pre-
cipitated with 2.5 volumes of ethanol, resuspended in the same
buffer and phenol extracted and precipitated as before. The pep-
tide-DNA complex was further purified by centrifugationas follows:
20 ml of peptide-DNA complex (0.25 mg/ml) in TES (50 mM Tris-
HCl, pH 7.8, 10 mM EDTA, 0.1 M NaCl) were layered on top of 10
ml of a solution of CsCl in TES with a density of 1,45 g x cm 3
and 5 ml of the same solution of density 1,70 g x cm 3 and cen-
trifuged during 25 hr. at 100,000 x g. Fractions containing DNA
were pooled, dialyzed extensively against 0,1 x SSC (0.15 MNaCl,
0.015 M sodium citrate) and precipitated with 2,5 volumes of
ethanol. Finally, the peptide-DNA complex was incubated, at a
concentration of 1 mg/ml, with 1 M piperidine, freshly distilled,
for 6 hr. at 370C. The sample was lyophylized, dissolved in 10%
formic acid and precipitated with two volumes of ethanol in the
presence of 0.5 M ammonium acetate. Aliquots of the supernatant
containing between 0.7 and 3.0 nmol of peptide were hydrolyzed
overnight at 1100C with 5.7 M HCl, 0.05% 2-mercaptoethanol. The
hydrolysates were analyzed in a Beckman 121-M B analyzer equipped
with a Beckman integrator 126 data system.
Purification of {1251}-labeled tryptic peptide linked to the DNA
by reverse phase high performance liquid chromatography
Protein p3-DNA complex from phage 029 delayed lysis mutant
susl4(1242) was prepared essentially as described (14). Phage
treated with guanidinium hydrochloride at a DNA concentration of
0.25 mg/ml was layered on top of a CsCl gradient between densi-
ties 1.55 and 1.45 g x cm 3 in TES buffer and centrifuged for
19 hr.at 120,000 x g. DNA containing fractions were pooled and
precipitated with ethanol.
Purified $29 terminal protein-DNA complex (100 vg) was labe-
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led in the tyrosine residues with {125I} (700 pCi) using the
chloramine T method (15) as described (9), precipitated with
ethanol, resuspended in 300 pl of 0.2. M N-methyl morpholine,
pH 8.0, and digested with 30 pl of trypsin (2 mg/ml) by incuba-
tion at 370C for 4 hr. The digested material was incubated for
5 min at 500C in the presence of 0.1% SOS and layered on
top of a CsCl linear gradient between densities 1.55 and 1.45 g
x cm 3 in TES buffer and centrifuged for 4.5 hr. at 300,000 x g.
Fractions sedimenting at the DNA position were pooled, dialyzed
against 10 mM ammonium acetate and lyophylized. The peptide was
released from the DNA by treatment with 1 M piperidine for 2 hr.
at 370C and the mixture was dissolved in 50 p1 of 0.1% trifluo-
roacetic acid (TFA) and applied to a p Bondapak C18 reverse pha-
se column (3.9 x 150 mm, from Waters). The column was run at
370C at a flow rate of 0.5 ml/min and developed with a linear
gradient of 0-30% acetonitrile in 0.1% TFA. Fractions of 0.5 ml
were collected for radioactivity measurements. The main radio-
active peak was pooled for further analysis.
Sequence analysis of the { 125I}-tryptic peptide
A 0.64 ml sample containing 140,000 cpm of the { 5Il-pepti-
de and 2.0 mg of sperm whale myoglobin were applied to the spin-
ning cup of a Beckman 890C sequencer. Polybrene (3 mg) was mixed
with the sample to avoid washout (16). Automated Edman degrada-
tion (17) was performed using the standard Beckman 0.1 M Quadrol
program. The amino acid thiazolinones obtained in each cycle were
used directly for radioactivity measurements. To check sequen-
cing accuracy, one third of the amino acid thiazolinones corres-
ponding to cycles 19, 20 and 21 were converted to phenylthiohy-
dantoin (PTH) amino acids (18) and identified by thin-layer chro-
matography (19). Alanine, aspartic acid and valine derivatives
were found, that correspond to the amino acids present at those
positions in myoglobin.
Carboxypeptidase digestion of the {1 5I}-tryptic peptide
Purified {1251}-labeled tryptic peptide containing the linking
site (1,000-3,000 cpm) was dried under vacuum together with 5 pg
of the synthetic peptide pro-phe-gly-lys as carrier, dissolved
in 10 pl of 10 mM sodium phosphate buffer, pH 7 and incubated at
300C for the indicated times with 0.1 pg (0,04 U) of carboxypep-
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tidase A and 0.06 pg (0,01 U) of carboxypeptidase B. The samples
were applied immediately to thin layer chromatography plates and
developed in n-butanol/acetic acid/water/pyridine (30:6:24:20).
The radioactive digestion products were detected by autoradio-
graphy and those from the carrier peptide and the marker 3-iodo-
tyrosine were identified by ninhydrin staining.
RESULTS
Identification of a peptide containing the linking site
Since proteolytic digestion of the 029 terminal protein-DNA
complex yields a peptide covalently attached to the DNA and the
linkage can be hydrolyzed by alkali (1), we have purified the
peptide that remains attached to 029 DNA after proteinase K di-
gestion by phenol extraction and CsCl gradient centrifugation.
After alkaline hydrolysis with piperidine and ethanol precipita-
tion to remove DNA, the material in the supernatant was hydroly-
zed with HCl and the amino acid composition determined. Table 1
shows the amino acid composition of two independent peptide pre-
parations in which a single serine residue was obtained. Glycine
could not be detected due to ninhydrin reacting contaminants,
probably DNA degradation products, that coelute at the correspon-
Table 1. Amino acid analysis of the proteinase K-resistant pep-
tide linked to 029 DNA.
Residue Observeda Predictedb
Asp 2.16 2
Thr 0.95 1
Ser 1.01 1
Gly N.D. 1
Glu 2.96 3
Val 1.07 1
Phe 0.95 1
aAverage amino acid composition (mol/mol of peptide) obtained by
three amino acid analysis of two independent peptide prepara-
tions. Amino acids present in amounts smaller than 0.1 mol/mol
of peptide are not included.
bAmino acid composition of the corresponding peptide predicted
from the nucleotide sequence (11) (see Figure 1).
N.D., not determined.
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ding position in the amino acid analysis. The amino acid compo-
sition obtained better fits with a decapeptide around serine at
position 232, either from position 228 to 237 or 229 to 238,
since the presence of glutamic acid in positions 228 and 238 does
not allow to determine the exact boundaries of the peptide (see
Fig. 1). Attempts to determine the N-terminal amino acid, either
by reaction with O-phtaladehyde (20) or dansyl-chloride (21,22)
failed, probably due to contamination of the peptide with DNA
degradation products containing amino groups.
Isolation and analysis of the t I25I-labeled tryptic peptide
linked to the DNA
According to the amino acid sequence of protein p3 (see Figu-
re 1), serine residue 232 is included in a tryptic peptide of
25 amino acids (from position 222 to 246) that contains two other
serine residues, at positions 223 and 226, and only one tyrosine
at position 245 (position 24 in the peptide), and is the largest
one of the molecule. To confirm the previous result, 029 termi-
nal protein-DNA complex was labeled with {125I} and digested with
25
M A R S P R I R I K D N D K A E Y A R L V K N T K
50
A K I A R T K K K Y G V D L T A E I D I P D L D S
75
F E T R A Q F N K W K E Q A S S F T N R A N M R Y
100
Q F E K N A Y G V V A S K A K I A E I E R N T K E
125
V Q R L V D E K I K A M K D K E Y Y A G G K P Q G
150
T I E Q R I A M T S P A H V T G I N R P H D F D F
175
S K V R S Y S R L R T L E E S M E M R T D P Q Y Y
200
E K K M I Q L Q L N F I K S V E G S F N S F D A A
225
D E L I E E L K K I P P D D F Y E L F L R I S E I
DI 250S FfEFD_E_N T V E N V E G N V Y K I L S Y
L E Q Y R R G D F D L S L K G F
Fig. 1. Amino acid sequence of 029 terminal protein deduced from
the nucleotide sequence of gene 3 (11). The serine residue through
which the terminal protein is covalently attached to the DNA is
encircled.(< - - ->) Possible peptides resistant to proteinase K
di¶estion of the terminal protein-029 DNA complex; (4 -)
{1 5Il-labeled tryptic peptide covalently linked to 029 DNA.
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FIig.i. Purification of {1251}-labeled tryptic peptide contai-
nling the linking site by reverse phase chromatography. {l25i}..
labeled tryptic peptide covalently linked to 029 DNA, purified
through CsCl gradient centrifugation as described in Materials
and M4ethods, was digested with 1 M piperidine for 2 hr. at 372C,
applied to reverse phase high performance liquid chromatography
column and eluted with a linear gradient of 0-30% acetonitrile
as described in Materials and Methods. The inset shows samples
electrophoresed in a 10-18% linear gradient of acrylamide gel
containing 0.1% SDS and 7 M urea (23). A. Sample from the DNA-
containing peak in the CsCl gradient. B. The same as A digested
with piperidine. C. {14C}-methylated low molecular weight mar-
kers carbonic anhydrase, soybean trypsin inhibitor, cytochrome
C, aprotinin and insulin, chain B and chain A.
trypsin. The {1251}-labeled trypt'ic peptide linked to the DN4A
was isolated by centrifugation in a CsCl gradient. The peptide
was released from the DNA by treatment with piperidine and puri-
fied by reverse phase high performance chromatography to remove
the DNA. Figure 2 shows that a main peak o-f radioactivity was
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obtained, with a 60% recovery. The inset shows the radioactive
peptide sedimenting at the position of the DNA in the CsCl gra-
dient electrophoresed in a polyacrylamide gel before and after
treatment with piperidine. The untreated sample (Figure 2, lane
A) remained in the origin indicating that all the radioactivity
is covalently linked to the DNA. After piperidine treatment
under conditions that hydrolyze the linkage (Figure 2, lane B),
the sample moved as a single band of Mr about 2,600, very close
ISE IS FEE F DSEGNTVENVEGNVYK
IF-
5 10 15 20
Cycle number
Fig. 3. Automated Edman degradation of { 125I-labeled tryptic
peptide containing the linking site. {1251}-labeled tryptic pep-
tide purified by reverse phase chromatography was sequenced toge-
ther with sperm whale myoglobin as carrier in a Beckman 890 C
sequencer using the standard Beckman 0.1 M Quadrol program. The
radioactivity of the amino acid thiazolinones released in each
cycle was determined. The amino acid sequence of the correspon-
ding peptide (see Figure 1) is shown in the upper part.
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to the theoretical Mr value (2,836) of the tryptic peptide con-
taining serine at position 232.
Location of the { 125I}-labeled tyrosine in the tryptic peptide
released from the DNA
To locate precisely the position of the { 125I}-labeled tyro-
sine in the tryptic peptide the latter was mixed with myoglobin
as carrier and subjetcted to 28 automated Edman degradation cycles.
The radioactivity released in each cycle is shown in Figure 3,
where a maximum is seen in step 24, corresponding to the position
of the tyrosine residue in the tryptic peptide. No other tryptic
peptide in the whole molecule, even partially digested, contains
a tyrosine residue in that position (see Figure 1).
In addition, the purified { 125I}-labeled tryptic peptide con-
taining the linking site was digested with a mixture of carboxy-
peptidases A and B and analyzed by thin layer chromatography.
Figure 4 shows that after 5 and 15 min of incubation at 30C
(lanes B and C) only two radioactive spots are observed, one with
the same mobility as the untreated peptide (lane A) and the
other with that of the 3-iodotyrosine marker. After 60 min of
incubation (lane D), all the radioactivity is released as 3-iodo-
tyrosine. These results suggest that the labeled tyrosine resi-
due lies close to the C-terminus of the peptide, in agreement
A B C D Fig. 4. Carboxypeptidase digestionof {125I}-labeled tryptic peptide
containing the linking site.
{125I}-labeled tryptic peptide
O3-ISnT rT purified by reverse phase chro-
a.. j¢ -- --- - 1X yr matography was incubated at 30QC
w4Ii* with a mixture of carboxypepti-
dases A and B for 5 min (lane B),
15min (lane C) and 60min (lane D),
applied immediately to cellulose
thin layer plates and developed as
indicated in Materials and Methods.
Lane A, untreated sample. The
position of 3-iodotyrosine marker
is also shown.
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Fig. 5. Secondary structure prediction of regions surrounding
the linking site in 029 and adenovirus-terminal proteins. Secon-
dary structure using the Chou and Fasman method (24) was predic-
ted for a 40 residues long region in which the linking site was
centered in the terminal proteins from 029 (A) and adenovirus
(B). Coil, a-helix; sawtooth pattern, 6-sheet; straight line,
random coil; arch, 6-turn. The amino acid sequence for both re-
gions, deduced from the nucleotide sequence (11,12), is also
shown. The arrows indicate the position of the serine residue
involved in the linkage.
with the sequencing data; otherwise, other labeled degradation
products would have been obtained.
Secondary structure around the linking site of the 029 terminal
protein
So far, the linking site has been characterized only in two
cases, adenovirus (12) and phage 029 (this paper). Since the me-
chanism of initiation of replication in which the terminal pro-
tein plays a major role as a primer is strikingly similar for
the two systems, we would expect structural similarities in the-
se proteins reflecting their function and, in particular, in the
region containing the linking site. The amino acid sequences of
the adenovirus and 029 terminal proteins in an arbitrary envi-
ronment from i-20 to i+20, iO being the linking site, do not pre-
sent any apparent sequence homology (see Figure 5). Nevertheless,
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Fig. 6. Hydropathic index of a 40 residues long region inclu-
ding the linking site, using a span setting of nine according to
Kyte and Doolittle (26). e-*, 029 terminal protein; o---o,
adenovirus terminal protein. The arrow indicates the location
of the linking site. The residue number corresponds to the 029
terminal protein.
the amino acid composition of this region is very similar in
both cases, containing about 25% acidic residues (aspartic acid,
glutamic acid), about 3% basic residues (lysine, arginine) and
about 25% non polar aliphatic large chain residues (valine, iso-
leucine, leucine). Figure 5 shows the predicted secondary struc-
ture for the i-20 to i+20 region in both proteins, using the
Chou and Fasman method (24). The linking sites, for either 029
or adenovirus terminal proteins, are probably located in s-turns
and both sites are preceded by a-helical regions.
Since s-turns are usually concentrated at the surface of the
protein (25), the hydropathic values (26), that is the hydropho-
bic and hydrophylic tendencies of a given amino acid in a poly-
peptide chain, were calculated for the i-20 to i+20 region ofthe
two terminal proteins. Figure 6 shows that the region containing
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the linking site of both 029 and adenovirus terminal proteins
has hydropathic values on the hydrophylic side of the midpoint
line and therefore, as expected, the linking site is probably
located on the surface of the molecules (26).
DISCUSSION
We have characterized two overlapping peptides containing
the DNA-linking site : one was obtained by tryptic digestion of
{1 I}-labeled terminal protein DNA-complex and contains three
serine residues at positions 223, 226 and 232; the other, obtai-
ned by proteinase K digestion and characterized by amino acid
analysis (see Table 1),fits well with the peptide containing se-
rine 232, either from position 228 to 237 or 229 to 238, and ru-
les out serine 223 as the DNA linking site. If serine 226 were
the one linked to the DNA, the peptide that better fits with the
amino acid composition is that between residues 226 and 243 (see
Fig. 1), being the number of observed residues twice the value
indicated in Table I. In this case, there are two discrepancies
between the observed amino acid analysis (two threonine and six
glutamic acid residues) and the predicted peptide (one threonine
and five glutamic acid residues). Furthermore, it also seems un-
likely that the DNA attached to serine 226 would protect from
the proteinase K digestion only the protein moiety located at
the C terminal site of this residue. Therefore, we conclude that
the linking site of the terminal protein of phage 029 DNA is
most likely the serine at position 232, 35 amino acids from the
carboxyl terminus of the protein. This result is in agreement
with experiments of in vitro mutagenesis of gene 3. When the C-
terminal amino acids (leu-lys-gly-phe) or (lys-gly-phe) of the
terminal protein were replaced by phe-asp-ala-val-val-tyr-lys-
ser or by leu-ile-asp and the mutated proteins assayed in vitro
for initiation complex formation, their specific activity was
lower than that of the intact terminal protein (27). Deletion
mutants in which the four C-terminal amino acids of the terminal
protein were removed showed a decrease in activity and when the
deletion was extended up to twenty amino acids, no activity was
detected (unpublished results). All these results indicate that
the C-terminal region is important for the activity of the ter-
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minal protein.
Secondary structure predictions for the region around the
linking site in 029 and adenovirus terminal proteins suggest that
both serine residues lie in a s-turn located after an a-helix
region. Hydropathic values have also been calculated and in both
cases the linking site is probably on the surface of the molecu-
le. Moreover, the hydropathic profile around such serine residues
are similar for both proteins, thus suggesting similar surface
topologies. The presence of a DNA molecule covalently linked to
this site, or even dAMP in the initiation complex, may drastical-
ly change both the secondary and tertiary structure of the prot-
ein, reflecting the different roles played by the free and parerr-
tal terminal proteins in the mechanism of initiation of replica-
tion of 029 DNA.
Although the free terminal protein plays most likely a struc-
tural role in the priming mechanism of initiation of 029 DNA re-
plication, it must contain several recognition sites to fulfill
its function. On the one hand, it interacts with the 029 DNA po-
lymerase (unpublished results). On the other, it should bind to
the parental terminal protein and/or a specific sequence at the
029 DNA ends and should contain a specific site through which
dAMP is covalently linked giving rise to the p3-dAMP initiation
complex. The linking site determined in this paper should be
the acceptor site of dATP for the formation of the initiation
complex. Modification of the terminal protein by site-directed
mutagenesis should be of help in correlating the structure of
the protein with its function as a primer in 029 DNA replication.
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